Ascelia Pharma AB (publ) (STO: ACE)

Ascelia Pharma AB Statistics

Total Valuation

Ascelia Pharma AB has a market cap or net worth of SEK 260.38 million. The enterprise value is 191.28 million.

Market Cap	260.38M
Enterprise Value	191.28M

Important Dates

The last earnings date was Thursday, November 7, 2024.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Ascelia Pharma AB has 96.08 million shares outstanding. The number of shares has increased by 11.83% in one year.

Current Share Class	n/a
Shares Outstanding	96.08M
Shares Change (YoY)	+11.83%
Shares Change (QoQ)	+52.17%
Owned by Insiders (%)	2.41%
Owned by Institutions (%)	19.54%
Float	93.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.42
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.07
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.25.

Current Ratio	3.77
Quick Ratio	3.56
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-10.34

Financial Efficiency

Return on equity (ROE) is -64.84% and return on invested capital (ROIC) is -32.64%.

Return on Equity (ROE)	-64.84%
Return on Assets (ROA)	-26.82%
Return on Capital (ROIC)	-32.64%
Revenue Per Employee	n/a
Profits Per Employee	-4.79M
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.47% in the last 52 weeks. The beta is 1.04, so Ascelia Pharma AB's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-7.47%
50-Day Moving Average	2.34
200-Day Moving Average	6.34
Relative Strength Index (RSI)	62.66
Average Volume (20 Days)	895,859

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-57.45M
Pretax Income	-62.46M
Net Income	-62.30M
EBITDA	-57.38M
EBIT	-57.45M
Earnings Per Share (EPS)	-1.63

Balance Sheet

The company has 95.72 million in cash and 26.62 million in debt, giving a net cash position of 69.10 million or 0.72 per share.

Cash & Cash Equivalents	95.72M
Total Debt	26.62M
Net Cash	69.10M
Net Cash Per Share	0.72
Equity (Book Value)	107.58M
Book Value Per Share	1.12
Working Capital	76.36M

Cash Flow

Operating Cash Flow	-59.99M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ascelia Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.83%
Shareholder Yield	-11.83%
Earnings Yield	-60.19%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a